Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

NCT07216859 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT07216859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07216859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2028
Completion date
November 1, 2028
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, masld - metabolic dysfunction-associated steatotic liver disease